ArticleLeukemia & lymphoma2023

Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms.

Noam E Kopmar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.